Michelle Moorhouse

2.6k total citations · 1 hit paper
46 papers, 1.4k citations indexed

About

Michelle Moorhouse is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Michelle Moorhouse has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 17 papers in Virology and 15 papers in Epidemiology. Recurrent topics in Michelle Moorhouse's work include HIV/AIDS Research and Interventions (34 papers), HIV/AIDS drug development and treatment (23 papers) and HIV Research and Treatment (17 papers). Michelle Moorhouse is often cited by papers focused on HIV/AIDS Research and Interventions (34 papers), HIV/AIDS drug development and treatment (23 papers) and HIV Research and Treatment (17 papers). Michelle Moorhouse collaborates with scholars based in South Africa, United Kingdom and United States. Michelle Moorhouse's co-authors include François Venter, Godspower Akpomiemie, Simiso Sokhela, Andrew Hill, Celicia Serenata, Francesca Conradie, Matthew Chersich, Bryony Simmons, Sergio Carmona and Alinda G. Vos and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Michelle Moorhouse

45 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

2019 442 citations François Venter, Michelle Moorhouse et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Moorhouse South Africa	15	1.1k	528	460	409	182	46	1.4k
Polly Clayden United States	14	898 0.8×	372 0.7×	451 1.0×	277 0.7×	123 0.7×	30	1.1k
Colette Smit Netherlands	16	912 0.8×	360 0.7×	685 1.5×	782 1.9×	94 0.5×	49	1.6k
Yvonne Gilleece United Kingdom	18	595 0.5×	174 0.3×	256 0.6×	440 1.1×	144 0.8×	58	937
Scott McCallister United States	22	1.7k 1.6×	734 1.4×	421 0.9×	944 2.3×	221 1.2×	54	2.1k
Raoul Moh Ivory Coast	17	821 0.8×	385 0.7×	245 0.5×	548 1.3×	116 0.6×	66	1.1k
Marco Floridia Italy	19	935 0.9×	373 0.7×	334 0.7×	362 0.9×	116 0.6×	99	1.2k
Fred C. Semitala Uganda	18	790 0.7×	231 0.4×	236 0.5×	519 1.3×	108 0.6×	103	1.0k
Torsak Bunupuradah Thailand	22	844 0.8×	492 0.9×	340 0.7×	244 0.6×	198 1.1×	93	1.2k
Catherine Dollfus France	23	1.6k 1.4×	759 1.4×	652 1.4×	545 1.3×	332 1.8×	62	2.0k
Hermann Bussmann United States	23	951 0.9×	634 1.2×	257 0.6×	465 1.1×	143 0.8×	49	1.3k

Countries citing papers authored by Michelle Moorhouse

Since Specialization

Citations

This map shows the geographic impact of Michelle Moorhouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Moorhouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Moorhouse more than expected).

Fields of papers citing papers by Michelle Moorhouse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Moorhouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Moorhouse. The network helps show where Michelle Moorhouse may publish in the future.

Co-authorship network of co-authors of Michelle Moorhouse

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Moorhouse. A scholar is included among the top collaborators of Michelle Moorhouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Moorhouse. Michelle Moorhouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wasmann, Roeland E., Godspower Akpomiemie, Nomathemba Chandiwana, et al.. (2024). Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa. British Journal of Clinical Pharmacology. 90(5). 1247–1257. 1 indexed citations

Moorhouse, Michelle, et al.. (2024). Associations between exposure to the U=U message and perceived HIV stigma among both the HIV and non-HIV adult populations in South Africa. SHILAP Revista de lepidopterología. 6(January). 1–17. 2 indexed citations

Bekker, Linda‐Gail, Dvora Joseph Davey, Katherine Gill, et al.. (2020). Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020. Southern African Journal of HIV Medicine. 21(1). 1152–1152. 28 indexed citations

Siedner, Mark J., Michelle Moorhouse, Bryony Simmons, et al.. (2020). Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase. Nature Communications. 11(1). 5922–5922. 59 indexed citations

Hermans, Lucas E., Sergio Carmona, Monique Nijhuis, et al.. (2020). Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study. PLoS Medicine. 17(2). e1003037–e1003037. 36 indexed citations

Ake, Julie A., et al.. (2020). Sex Differences in the Treatment of HIV. Current HIV/AIDS Reports. 17(4). 373–384. 10 indexed citations

Chandiwana, Nomathemba, Matthew Chersich, François Venter, et al.. (2020). Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa. AIDS. 35(2). 205–211. 11 indexed citations

Venter, François, Michelle Moorhouse, Simiso Sokhela, et al.. (2019). Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. New England Journal of Medicine. 381(9). 803–815. 442 indexed citations breakdown →

Venter, François, Michelle Moorhouse, Simiso Sokhela, et al.. (2019). Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial. The Lancet HIV. 6(7). e428–e437. 12 indexed citations

10.

Dlamini, Sipho, Shabir A. Madhi, Rudzani Muloiwa, et al.. (2018). Guidelines for the vaccination of HIV-infected adolescents and adults in South Africa. Southern African Journal of HIV Medicine. 19(1). 839–839. 8 indexed citations

11.

Moorhouse, Michelle, Sergio Carmona, Natasha Davies, et al.. (2018). Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy. Southern African Journal of HIV Medicine. 19(1). 917–917. 9 indexed citations

12.

Vos, Alinda G., Matthew Chersich, Kerstin Klipstein‐Grobusch, et al.. (2018). Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir. Retrovirology. 15(1). 77–77. 10 indexed citations

13.

Eakle, Robyn, Gabriela B. Gomez, Judie Mbogua, et al.. (2017). HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project. PLoS Medicine. 14(11). e1002444–e1002444. 115 indexed citations

14.

Hermans, Lucas E., Michelle Moorhouse, Sergio Carmona, et al.. (2017). Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. The Lancet Infectious Diseases. 18(2). 188–197. 112 indexed citations

15.

Meintjes, Graeme, Michelle Moorhouse, Sergio Carmona, et al.. (2017). Adult antiretroviral therapy guidelines 2017. Southern African Journal of HIV Medicine. 18(1). 776–776. 142 indexed citations

16.

Venter, François, Mohammed Majam, Godspower Akpomiemie, et al.. (2017). Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial. BMC Public Health. 17(S3). 445–445. 4 indexed citations

17.

Bekker, Linda‐Gail, Kevin Rebe, François Venter, et al.. (2016). Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection. Southern African Journal of HIV Medicine. 17(1). 455–455. 78 indexed citations

18.

Bekker, Linda‐Gail, Kevin Rebe, François Venter, et al.. (2016). Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection. SHILAP Revista de lepidopterología. 58(5). 6–17. 2 indexed citations

19.

Moorhouse, Michelle, Linda‐Gail Bekker, Vivian Black, et al.. (2015). Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update. Southern African Journal of HIV Medicine. 16(1). 399–399. 13 indexed citations

20.

Meintjes, Graeme, Francesca Conradie, Vivian Cox, et al.. (2014). Adult antiretroviral therapy guidelines 2014 : guideline. Southern African Journal of HIV Medicine. 15(4). 121–143. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact